WORLAND STEPHEN T 4
4 · eFFECTOR Therapeutics, Inc. · Filed Aug 14, 2023
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-08-11−33,799→ 0 totalExercise: $0.52Exp: 2023-12-16→ Common Stock (33,799 underlying) - Exercise/Conversion
Common Stock
2023-08-11$0.52/sh+33,799$17,575→ 261,225 total
Holdings
- 562,339(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The stock option vests 25% on December 17, 2014, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.